A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
| Image |  |
|---|---|
| Description | scientific article published on 23 April 2008 |
| Author/s |
author: Gilberto Schwartsmann |
| Publication date | April 23, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |